Swiss National Bank Has $560,000 Stake in Anterix Inc. (NASDAQ:ATEX)

Swiss National Bank reduced its stake in shares of Anterix Inc. (NASDAQ:ATEXFree Report) by 16.5% during the 4th quarter, Holdings Channel.com reports. The firm owned 18,250 shares of the company’s stock after selling 3,600 shares during the quarter. Swiss National Bank’s holdings in Anterix were worth $560,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of ATEX. Point72 DIFC Ltd increased its position in Anterix by 440.8% in the third quarter. Point72 DIFC Ltd now owns 2,639 shares of the company’s stock worth $99,000 after purchasing an additional 2,151 shares during the period. Y Intercept Hong Kong Ltd boosted its stake in shares of Anterix by 14.6% in the 3rd quarter. Y Intercept Hong Kong Ltd now owns 8,742 shares of the company’s stock valued at $329,000 after purchasing an additional 1,112 shares during the last quarter. Allspring Global Investments Holdings LLC grew its position in shares of Anterix by 8,107.4% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 11,080 shares of the company’s stock worth $333,000 after buying an additional 10,945 shares during the period. Inspire Investing LLC raised its position in shares of Anterix by 19.4% during the 4th quarter. Inspire Investing LLC now owns 13,018 shares of the company’s stock valued at $399,000 after acquiring an additional 2,115 shares during the last quarter. Finally, Centiva Capital LP acquired a new position in shares of Anterix during the 3rd quarter worth about $445,000. Institutional investors and hedge funds own 87.67% of the company’s stock.

Anterix Stock Performance

Shares of Anterix stock opened at $35.76 on Monday. The business’s 50 day simple moving average is $35.59 and its 200 day simple moving average is $34.20. The firm has a market cap of $664.67 million, a PE ratio of -21.94 and a beta of 0.86. Anterix Inc. has a 52-week low of $27.37 and a 52-week high of $42.91.

Wall Street Analysts Forecast Growth

Separately, JPMorgan Chase & Co. raised their price objective on Anterix from $61.00 to $67.00 and gave the stock an “overweight” rating in a research note on Thursday, February 13th.

View Our Latest Research Report on Anterix

Anterix Profile

(Free Report)

Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.

Recommended Stories

Want to see what other hedge funds are holding ATEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anterix Inc. (NASDAQ:ATEXFree Report).

Institutional Ownership by Quarter for Anterix (NASDAQ:ATEX)

Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.